{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:26:37Z","timestamp":1754486797908},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,15]]},"DOI":"10.2146\/ajhp100704","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T18:06:47Z","timestamp":1314814007000},"page":"1707-1710","source":"Crossref","is-referenced-by-count":7,"title":["Myoclonus associated with long-term use of diltiazem"],"prefix":"10.1093","volume":"68","author":[{"given":"Michael T.","family":"Swanoski","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Minnesota (UM), Duluth, and Clinical Specialist, Essentia Health, Duluth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, UM, Duluth, and Essentia Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Monson","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Minnesota (UM), Duluth, and Clinical Specialist, Essentia Health, Duluth"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041106040759100_b1-0681707","volume-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII)","author":"National Heart Lung, and Blood Institute; National High Blood Pressure Education Program","year":"2004"},{"issue":"(suppl 24)","key":"key\n\t\t\t\t2019041106040759100_b2-0681707","first-page":"1","article-title":"2005 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"112","author":"ECC Committee, Subcommittees and Task Forces of the American Heart Association","year":"2005","journal-title":"Circulation."},{"key":"key\n\t\t\t\t2019041106040759100_b3-0681707","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.22.1","article-title":"Studies on a new 1,5-benzothiazepine derivative (CRD-401). II. Vasodilator actions","volume":"22","author":"Nagao","year":"1972","journal-title":"Jpn J Pharmacol."},{"key":"key\n\t\t\t\t2019041106040759100_b4-0681707","volume-title":"Diltiazem hydrochloride extended-release capsules package insert","year":"2008"},{"key":"key\n\t\t\t\t2019041106040759100_b5-0681707","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-8703(81)90128-9","article-title":"Electro-physiologic and hemodynamic actions of diltiazem: disparate temporal effects shown by experimental dose-response studies","volume":"101","author":"Fujimoto","year":"1981","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019041106040759100_b6-0681707","unstructured":"Drugdex. Calcium channel blocker induced-myoclonus. www.thomsonhc.com (accessed 2010 Dec 20)."},{"key":"key\n\t\t\t\t2019041106040759100_b7-0681707","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1756285610395653","article-title":"Myoclonic disorders: a practical approach for diagnosis and treatment","volume":"4","author":"Kojovic","year":"2011","journal-title":"Ther Adv Neurol Disord."},{"key":"key\n\t\t\t\t2019041106040759100_b8-0681707","first-page":"447","article-title":"Diltiazem-induced myclonus","volume":"92","author":"Jeret","year":"1992","journal-title":"N Y State J Med."},{"key":"key\n\t\t\t\t2019041106040759100_b9-0681707","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1212\/WNL.58.6.984","article-title":"Multifocal myoclonus due to verapamil overdose","volume":"58","author":"Vadlamudi","year":"2002","journal-title":"Neurology."},{"key":"key\n\t\t\t\t2019041106040759100_b10-0681707","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7326\/0003-4819-103-1-154_1","article-title":"Verapamil and myoclonic dystonia","volume":"103","author":"Hicks","year":"1985","journal-title":"Ann Intern Med."},{"key":"key\n\t\t\t\t2019041106040759100_b11-0681707","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/bmj.1.6127.1619-d","article-title":"Side effects of nifedipine","volume":"1","author":"Rodger","year":"1978","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2019041106040759100_b12-0681707","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000185303","article-title":"Nifedipine and myoclonic disorders","volume":"51","author":"Pedro-Botet Bonal","year":"1989","journal-title":"Nephron."},{"key":"key\n\t\t\t\t2019041106040759100_b13-0681707","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.amjmed.2008.10.036","article-title":"Amlodipine-induced myoclonus","volume":"122","author":"Wallace","year":"2009","journal-title":"Am J Med."},{"key":"key\n\t\t\t\t2019041106040759100_b14-0681707","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneur.64.9.1318","article-title":"Whole-body tremulousness: isolated generalized polymyoclonus","volume":"64","author":"McKeon","year":"2007","journal-title":"Arch Neurol."},{"key":"key\n\t\t\t\t2019041106040759100_b15-0681707","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanism and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin Pharmacol Ther."},{"key":"key\n\t\t\t\t2019041106040759100_b16-0681707","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin Pharmacokinet."},{"key":"key\n\t\t\t\t2019041106040759100_b17-0681707","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/18\/1707\/28350185\/ajhp1707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T13:58:26Z","timestamp":1560520706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/18\/1707\/5129323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":17,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011,9,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100704","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,9,15]]},"published":{"date-parts":[[2011,9,15]]}}}